Today's top medical abstracts
Pharma
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Pharma
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pharma
        Biotechnology
        Conferences/Meetings
        Drug Trials
        Drug/Product Approvals
        Execs on the Move
        Financial Reports
        M&A/Partnerships
        Marketing/Media/ROI
        Medical Devices/Products
        Physician/Patient Trends
        Popular Press
        Regulatory Issues
        Research & Development
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor


testArticles: Drug Trials
Latest (0) Month's Top Read  
Receive daily email updates on Drug Trials
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
Corporate News Releases, 07/07/08

SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
Corporate News Releases, 07/07/08

Randomized phase III trial comparing single-agent paclitaxel poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer
Journal of Thoracic Oncology, 07/07/08

Erbitux Enhanced Efficacy Demonstrated in Patients With KRAS Wild-Type Tumors in 1st-Line Metastatic Colorectal Cancer
PharmiWeb, 07/03/08

V.A.C.(R) Therapy Clinical Study in Japan Shows Significant Efficacy in the Treatment of Acute Wounds
Corporate News Releases, 07/03/08

New Data Show Preemptive Treatment May Significantly Reduce Skin Toxicities in Patients Receiving Vectibix(R) (Panitumumab)
PharmiWeb, 07/01/08

Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with
Corporate News Releases, 07/01/08

Mercks Investigational Migraine Treatment Telcagepant Improved Pain and Migraine-Associated Symptoms in Phase III Study
Merck & Co., 07/01/08

Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial
Current Medical Research and Opinion, 07/01/08

Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials
Current Medical Research and Opinion, 07/01/08
Receive daily email updates on Drug Trials
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb more...
250 Available Pages
First    Prev    16      17      18      19      20      21      22      23      24      25      Next      Last
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.